Alteration of saliva and blood ghrelin, obestatin, leptin and weight based on adjuvant chemotherapy treatment in early-stage operated breast cancer patients
Blood and salivary totalghrelin, obestatin and leptin levels are measured by using ELISA.Results: The mean ± SD weight (67.2 ± 12.3 and 72.9 ± 11.8 kg., p
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Aim: To evaluate the weight change and ghrelin, obestatin and leptin levels in operated early stage breast cancer patients receivingadjuvant chemotherapy.Material and Methods: This study was conducted with 22 operated breast cancer patients (examined before and after adjuvantchemotherapy) and 33 BMI-matched two different healthy controls (of 33 healthy controls, 17 BMI-matched control was usedto compare before adjuvant chemotherapy, 16 BMI-matched control was used to compare after adjuvant chemotherapy).
📊
Key Findings & Data:Age,anthropometric measurements (weight, BMI, waist circumference), and blood biochemistry were recorded.
💡
Conclusion & Impact:Blood and salivary totalghrelin, obestatin and leptin levels are measured by using ELISA.Results: The mean ± SD weight (67.2 ± 12.3 and 72.9 ± 11.8 kg., p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Aim: To evaluate the weight change and ghrelin, obestatin and leptin levels in operated early stage breast cancer patients receivingadjuvant chemotherapy.Material and Methods: This study was conducted with 22 operated breast cancer patients (examined before and after adjuvantchemotherapy) and 33 BMI-matched two different healthy controls (of 33 healthy controls, 17 BMI-matched control was usedto compare before adjuvant chemotherapy, 16 BMI-matched control was used to compare after adjuvant chemotherapy). Age,anthropometric measurements (weight, BMI, waist circumference), and blood biochemistry were recorded. Blood and salivary totalghrelin, obestatin and leptin levels are measured by using ELISA.Results: The mean ± SD weight (67.2 ± 12.3 and 72.9 ± 11.8 kg., p
🔖
Cite This Article
YARDIM, M., KARAOĞLU, A., AYDIN, S., YILMAZ, N., UGUR, K. (2022). Alteration of saliva and blood ghrelin, obestatin, leptin and weight based on adjuvant chemotherapy treatment in early-stage operated breast cancer patients. Annals of Medical Research, Cilt: 27 - Sayı: 3, 913–920. https://ajindex.com/articles/446464
T. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:359-86
Fujii T, Le Du F, Xiao L, et al. Effectiveness of an adjuvant chemotherapy regimen for early-stage breast cancer: a systematic review and network meta-analysis. JAMA Oncol 2015;1:1311-8
Autier P, Boniol M, Gavin A, et al. Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database. BMJ 2011;343:4411
Villarini A, Pasanisi P, Raimondi M, et al. Preventing weight gain during adjuvant chemotherapy for breast cancer: a dietary intervention study. Breast Cancer Res Treat 2012;135:581-9
Vance V, Mourtzakis M, McCargar L, et al. Weight gain in breast cancer survivors: prevalence, pattern and health consequences. Obes Rev 2011;12:282-94
Demark-Wahnefried W, Peterson BL, Winer EP, et al. Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 2001;19:2381-9
Buch K, Gunmalm V, Andersson M, et al. Effect of chemotherapy and aromatase inhibitors in the adjuvant treatment of breast cancer on glucose and insulin metabolism-A systematic review Cancer Med 2019;8:238-45
Nakazato M, Murakami N, Date Y, et al. A role for ghrelin in the central regulation of feeding. Nature 2001;409:194-8
Soriano-Guillen L, Barrios V, Campos-Barros A, et al. Ghrelin levels in obesity and anorexia nervosa: effect of weight reduction or recuperation. J Pediatr 2004;144:36-42
Masuda Y, Tanaka T, Inomata N, et al. Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun 2000;276:905-8
Garcia JM, Garcia-Touza M, Hijazi RA, et al. Active ghrelin levels and active/total ghrelin ratio in cancerinduced cachexia. J Clin Endocrinol Metab 2005; 90:2920-6
Zhang JV, Ren PG, Avsian-Kretchmer O, et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin’s effects on food intake. Science 2005;310:996-9
Lauwers E, Landuyt B, Arckens L, et al. Obestatin does not activate orphan G protein-coupled receptor GPR39. Biochem Biophys Res Commun 2006;351:21- 5
Aydin S. Discovery of ghrelin hormone: re searches and clinical applications. Turk J Biochem 2007;32: 76-89
Staiger H, Tschritter O, Machan J. Relationship of serum adip